Patents by Inventor Joon Chong YEE

Joon Chong YEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230184791
    Abstract: Provided herein are methods of quantifying extracellular vesicle concentration, such as exosomes, by measuring cholesterol content in a sample. Also provided are methods of processing extracellular vesicles to remove non-exosomal species which contain cholesterol.
    Type: Application
    Filed: January 15, 2021
    Publication date: June 15, 2023
    Applicant: Codiak Biosciences, Inc.
    Inventors: Kevin P. DOOLEY, Aaron J. SULENTIC, Shelly A. MARTIN, David LECHNER, Charlotte M. PIARD, Joon Chong YEE, Leila ALBERS
  • Publication number: 20230103511
    Abstract: The invention is a method of preventing the generation of pink color during antibody manufacturing by either preventing the reduction of antibodies during manufacturing and harvest or inhibiting the conversion of cyanocobalamin (CN-Cbl) to hydroxocobalamin (HO-Cbl) during manufacturing and harvest. Replacement of white light in the cell culture media preparation and storage areas with red light inhibits the conversion of CN-Cbl to HO-Cbl. Addition of peroxides to the clarified bulk at harvest inhibits reduction of the antibody disulfide bonds.
    Type: Application
    Filed: May 8, 2018
    Publication date: April 6, 2023
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Cheng DU, Ameya Umesh BORWANKAR, Joon Chong YEE, Zhijun TAN
  • Publication number: 20200255785
    Abstract: The present invention relates to the use of online biomass capacitance monitoring in perfusion cultures as a way to minimize volumes of cell culture media in large-scale manufacturing. In certain embodiments, a biomass capacitance probe is used to measure the viable cell density, and the viable cell density is used in conjunction with a pre-determined constant cell-specific perfusion rate to identify a target perfusion rate.
    Type: Application
    Filed: September 14, 2018
    Publication date: August 13, 2020
    Applicant: Bristol-Myers Squibb Company
    Inventors: Timothy C. ERLANDSON, Joon Chong YEE, Sarbajita RAY, Michael Christopher BOYS, Charles Anthony HILL